AACR 2019: Gilteritinib improved survival for patients with acute myeloid leukaemia
Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for patients with relapsed or refractory…
Browsing: FLT3-mutated AML
Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for patients with relapsed or refractory…